267 related articles for article (PubMed ID: 15528154)
41. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.
Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L
Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086
[TBL] [Abstract][Full Text] [Related]
42. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
[TBL] [Abstract][Full Text] [Related]
43. Hemochromatosis in Ireland and HFE.
Ryan E; O'keane C; Crowe J
Blood Cells Mol Dis; 1998 Dec; 24(4):428-32. PubMed ID: 9851896
[TBL] [Abstract][Full Text] [Related]
44. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
45. Pathophysiology of hereditary hemochromatosis.
Fleming RE; Britton RS; Waheed A; Sly WS; Bacon BR
Semin Liver Dis; 2005 Nov; 25(4):411-9. PubMed ID: 16315135
[TBL] [Abstract][Full Text] [Related]
46. [Mutations in the HFE gene in patients with rheumatic diseases].
Půtová I; Cimburová M; Jarosová K; Vencovský J; Horák J
Cas Lek Cesk; 2005; 144(6):391-7; discussion 397-8. PubMed ID: 16047841
[TBL] [Abstract][Full Text] [Related]
47. Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy.
Cassanelli S; Pignatti E; Montosi G; Garuti C; Mariano M; Campioli D; Carbonieri A; Baldini E; Pietrangelo A
J Hepatol; 2001 Apr; 34(4):523-8. PubMed ID: 11394651
[TBL] [Abstract][Full Text] [Related]
48. Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis.
Bozzini C; Campostrini N; Trombini P; Nemeth E; Castagna A; Tenuti I; Corrocher R; Camaschella C; Ganz T; Olivieri O; Piperno A; Girelli D
Blood Cells Mol Dis; 2008; 40(3):347-52. PubMed ID: 18164223
[TBL] [Abstract][Full Text] [Related]
49. Frequency of the HFE C282Y and H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods.
Milman N; Koefoed P; Pedersen P; Nielsen FC; Eiberg H
Eur J Haematol; 2003 Dec; 71(6):403-7. PubMed ID: 14703688
[TBL] [Abstract][Full Text] [Related]
50. Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations.
Flanagan JM; Peng H; Beutler E
Alcohol Clin Exp Res; 2007 Jan; 31(1):138-43. PubMed ID: 17207112
[TBL] [Abstract][Full Text] [Related]
51. HFE gene C282Y, H63D and S65C mutations frequency in the Transylvania region, Romania.
Trifa AP; Popp RA; Militaru MS; Farcaş MF; Crişan TO; Gana I; Cucuianu A; Pop IV
J Gastrointestin Liver Dis; 2012 Jun; 21(2):177-80. PubMed ID: 22720307
[TBL] [Abstract][Full Text] [Related]
52. Differential HFE allele expression in hemochromatosis heterozygotes.
Rosmorduc O; Poupon R; Nion I; Wendum D; Feder J; Béréziat G; Hermelin B
Gastroenterology; 2000 Oct; 119(4):1075-86. PubMed ID: 11040194
[TBL] [Abstract][Full Text] [Related]
53. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
[TBL] [Abstract][Full Text] [Related]
54. Mutation analysis of the HFE gene in German hemochromatosis patients and controls using automated SSCP-based capillary electrophoresis and a new PCR-ELISA technique.
Hellerbrand C; Bosserhoff AK; Seegers S; Lingner G; Wrede C; Lock G; Schölmerich J; Büttner R
Scand J Gastroenterol; 2001 Nov; 36(11):1211-6. PubMed ID: 11686223
[TBL] [Abstract][Full Text] [Related]
55. HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis.
Distante S; Berg JP; Lande K; Haug E; Bell H
Gut; 2000 Oct; 47(4):575-9. PubMed ID: 10986220
[TBL] [Abstract][Full Text] [Related]
56. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM
Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
[TBL] [Abstract][Full Text] [Related]
57. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
Nelson JE; Brunt EM; Kowdley KV;
Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
[TBL] [Abstract][Full Text] [Related]
58. Non-HFE hemochromatosis.
Pietrangelo A
Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
[TBL] [Abstract][Full Text] [Related]
59. Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice.
Nicolas G; Andrews NC; Kahn A; Vaulont S
Blood; 2004 Apr; 103(7):2841-3. PubMed ID: 14656876
[TBL] [Abstract][Full Text] [Related]
60. HFE based re-evaluation of heterozygous hemochromatosis.
Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
